Opportunity ID: 331897

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-141
Funding Opportunity Title: AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 04, 2021
Last Updated Date: Mar 04, 2021
Original Closing Date for Applications: Sep 07, 2023
Current Closing Date for Applications: Sep 07, 2023
Archive Date: Oct 13, 2023
Estimated Total Program Funding:
Award Ceiling: $400,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Public and State controlled institutions of higher education
State governments
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: It is essential to expand and diversify the skilled AD/ADRD clinical trial workforce. The intent of this Funding Opportunity Announcement (FOA) is to encourage applications that develop creative and innovative short courses to train the next generation of AD/ADRD clinical trialists in state-of-the-art clinical research skills.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-141.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 331897 Full Announcement-PAR-21-141 -> PAR-21-141-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00265778 Apr 25, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269521 Oct 27, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277543 Oct 28, 2022 Sep 07, 2023 View

Package 1

Mandatory forms

331897 RR_SF424_2_0-2.0.pdf

331897 PHS398_CoverPageSupplement_5_0-5.0.pdf

331897 RR_OtherProjectInfo_1_4-1.4.pdf

331897 PerformanceSite_2_0-2.0.pdf

331897 RR_KeyPersonExpanded_2_0-2.0.pdf

331897 RR_Budget_1_4-1.4.pdf

331897 PHS398_ResearchPlan_4_0-4.0.pdf

331897 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

331897 RR_SubawardBudget30_1_4-1.4.pdf

331897 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

331897 RR_SF424_5_0-5.0.pdf

331897 PHS398_CoverPageSupplement_5_0-5.0.pdf

331897 RR_OtherProjectInfo_1_4-1.4.pdf

331897 PerformanceSite_4_0-4.0.pdf

331897 RR_KeyPersonExpanded_4_0-4.0.pdf

331897 RR_Budget_3_0-3.0.pdf

331897 PHS398_ResearchPlan_4_0-4.0.pdf

331897 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

331897 RR_SubawardBudget30_3_0-3.0.pdf

331897 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

331897 RR_SF424_5_0-5.0.pdf

331897 PHS398_CoverPageSupplement_5_0-5.0.pdf

331897 RR_OtherProjectInfo_1_4-1.4.pdf

331897 PerformanceSite_4_0-4.0.pdf

331897 RR_Budget_3_0-3.0.pdf

331897 PHS398_ResearchPlan_5_0-5.0.pdf

331897 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

331897 RR_SubawardBudget30_3_0-3.0.pdf

331897 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T19:15:17-05:00

Share This Post, Choose Your Platform!

About the Author: